Quanterix (QTRX) EPS (Basic) Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.42% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.04% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.88% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 95.65% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 8.20% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 92.59% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -30.89% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 51.01% |
| 10 | Quanterix | 165.84 Mn | 66.57 Mn | 15.57 Mn | 30.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.19% |
| Dec 31, 2025 | -56.67% |
| Sep 30, 2025 | -231.82% |
| Jun 30, 2025 | -305.26% |
| Mar 31, 2025 | -82.76% |
| Dec 31, 2024 | -30.43% |
| Sep 30, 2024 | -22.22% |
| Jun 30, 2024 | -26.67% |
| Mar 31, 2024 | -52.63% |
| Dec 31, 2023 | 53.06% |
| Sep 30, 2023 | 81.82% |
| Jun 30, 2023 | 79.45% |
| Mar 31, 2023 | 61.22% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | -130.23% |
| Jun 30, 2022 | -121.21% |
| Mar 31, 2022 | -68.97% |
| Dec 31, 2021 | -58.06% |
| Sep 30, 2021 | -714.29% |
| Jun 30, 2021 | 23.26% |
| Mar 31, 2021 | 29.27% |
| Dec 31, 2020 | 20.51% |
| Sep 30, 2020 | 118.92% |
| Jun 30, 2020 | 6.52% |
| Mar 31, 2020 | 2.38% |
| Dec 31, 2019 | 7.14% |
| Sep 30, 2019 | -5.71% |
| Jun 30, 2019 | -35.29% |
| Mar 31, 2019 | -27.27% |
| Dec 31, 2018 | 60.38% |
| Sep 30, 2018 | 88.82% |
| Jun 30, 2018 | 89.41% |
| Mar 31, 2018 | 89.62% |